(Q39160733)

9 September 2017

title

Paclitaxel nanosuspensions for targeted chemotherapy - nanosuspension preparation, characterization, and use. (English)

1 reference

9 September 2017

1 reference

13

Robert M Hoffman

1 reference

9 September 2017

Sarah E Lee

1

1 reference

9 September 2017

Shawn F Bairstow

2

1 reference

9 September 2017

Jane O Werling

3

1 reference

9 September 2017

Mahesh V Chaubal

4

1 reference

9 September 2017

Lawrence Lin

5

1 reference

9 September 2017

Mary Ann Murphy

6

1 reference

9 September 2017

James P DiOrio

7

1 reference

9 September 2017

Jerome Gass

8

1 reference

9 September 2017

Barrett Rabinow

9

1 reference

9 September 2017

Xiaoen Wang

10

1 reference

9 September 2017

Yong Zhang

11

1 reference

9 September 2017

Zhijian Yang

12

1 reference

9 September 2017

publication date

25 April 2013

1 reference

Pharmaceutical Development and Technology

9 September 2017

published in

1 reference

9 September 2017

volume

19

1 reference

9 September 2017

issue

4

1 reference

9 September 2017

page(s)

438-453

1 reference

Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2013.789911

Role of formulation vehicles in taxane pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2013.789911

THE DEVELOPMENT AND CLINICAL UTILITY OF THE TAXANE CLASS OF ANTIMICROTUBULE CHEMOTHERAPY AGENTS

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2013.789911

Paclitaxel and its formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2013.789911

In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2013.789911

Impact of intraperitoneal, sustained delivery of paclitaxel on the expression of P-glycoprotein in ovarian tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2013.789911

Are there curative options to peritoneal carcinomatosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2013.789911

Surgical margins and survival after head and neck cancer surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2013.789911

Albendazole: a potent inhibitor of vascular endothelial growth factor and malignant ascites formation in OVCAR-3 tumor-bearing nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2013.789911

Proceedings of a GOG workshop on intraperitoneal therapy for ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2013.789911

Weekly paclitaxel in ovarian cancer-the latest success story

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2013.789911

Update on chemotherapeutic agents utilized for perioperative intraperitoneal chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2013.789911

Cell kill kinetics and cell cycle effects of taxol on human and hamster ovarian cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2013.789911

Itraconazole IV nanosuspension enhances efficacy through altered pharmacokinetics in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2013.789911

The CD14+ CD16+ blood monocytes: their role in infection and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2013.789911

Monocyte subpopulations and their differentiation patterns during infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2013.789911

Monocyte and macrophage heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2013.789911

Intraperitoneal cisplatin and paclitaxel in ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2013.789911

Effective relief of malignant ascites in patients with advanced ovarian cancer by a trifunctional anti-EpCAM x anti-CD3 antibody: a phase I/II study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2013.789911

Polymeric drug delivery systems for localized cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2013.789911

Tumor-Associated Macrophages in Cancer Growth and Progression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10837450.2013.789911

10.3109/10837450.2013.789911

21 January 2018

Identifiers

DOI

1 reference

9 September 2017

1 reference